Alumni raised $1.45B in 2022 - Download Free Report Now

Rempex Pharmaceuticals

New antibacterial drugs that target multi-drug resistant pathogens.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Rempex Pharmaceuticals plus 5521 other startups.

Start Free 7 Day Trial Now

Learn More About Rempex Pharmaceuticals

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With